JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease (Q48031349)
Jump to navigation
Jump to search
scientific article published on 24 September 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease |
scientific article published on 24 September 2014 |
Statements
1 reference
JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease (English)
1 reference
Brian C Shook
Stefanie Rassnick
Paul F Jackson
Kenneth Rhodes
Abdallah Ahnaou
Paula Te Riele
Brian Hrupka
Patrick De Haes
Herman Hendrickx
Nancy Aerts
Koen Hens
Annemie Wellens
Jef Vermeire
24 September 2014
1 reference